Acorda Therapeutics (ACOR) Reports First Quarter 2013 Financial Results
5/2/2013 8:10:27 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced its financial results for the first quarter ended March 31, 2013.
“AMPYRA sales were pressured in the first part of the quarter, consistent with the seasonal pattern we have seen in prior years and in line with our internal projections.
Help employers find you! Check out all the jobs and post your resume.
comments powered by